It has been established that Cu can activate the NF-κB signaling pathway, causing increased production of several inflammatory factors (Liu et al., 2020, 2021; Tastan et al., 2021) and APOE activity activation (Du et al., 2005), ultimately driving AD progression. This evidence concerns the gene NFKB1 and Alzheimer disease.